| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Mar―05 |
The S1 spike protein of SARS-CoV-2 upregulates the ERK/MAPK signaling pathway in DC-SIGN-expressing THP-1 cells |
Emma Lee Johnson, Yuki Ohkawa, Noriko Kanto, Reiko Fujinawa, Taiki Kuribara, Eiji Miyoshi, Naoyuki Taniguchi |
| 2 |
[GO] |
2023―Nov―15 |
Heat shock protein 27 in the pathogenesis of COVID-19 and non-COVID acute respiratory distress syndrome |
Michael H. Chiu, Benjamin Gershkovich, Ian-Ling Yu, Edward R. O’Brien, Jingti Deng, Braedon McDonald |
| 3 |
[GO] |
2023―Oct―05 |
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway |
Rabab S. Hamad, Hayder M. Al-kuraishy, Athanasios Alexiou, Marios Papadakis, Eman A. Ahmed, Hebatallah M. Saad, Gaber El-Saber Batiha |
| 4 |
[GO] |
2023―Feb―17 |
Investigation of inflammation, oxidative stress, and DNA damage in COVID-19 patients |
Muhammet Yusuf Tepebaşı, İlter İlhan, Esra Nurlu Temel, Okan Sancer, Önder Öztürk |
| 5 |
[GO] |
2023―Feb―08 |
Hippo-YAP signaling and SARS-CoV-2 infection: a new mechanistic pathway |
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha |
| 6 |
[GO] |
2022―Nov―23 |
Transcription factor Nrf2 as a potential therapeutic target for COVID-19 |
Yifan Wang, Jing Ma, Yongfang Jiang |
| 7 |
[GO] |
2021―Nov―30 |
Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19 |
Philip L. Hooper |
| 8 |
[GO] |
2021―Nov―09 |
Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19? |
Paola Finotti |
| 9 |
[GO] |
2021―Aug―12 |
Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies |
Andrii Puzyrenko, Elizabeth R. Jacobs, Yunguang Sun, Juan C. Felix, Yuri Sheinin, Linna Ge, et al. (+8) Shuping Lai, Qiang Dai, Benjamin N. Gantner, Rahul Nanchal, Paula E. North, Pippa M. Simpson, Hallgeir Rui, Ivor J. Benjamin |
| 10 |
[GO] |
2021―May―11 |
SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity |
Stefano Burgio, Everly Conway de Macario, Alberto JL Macario, Francesco Cappello |
| 11 |
[GO] |
2021―Feb―24 |
CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients |
M. Hernandez-Cedeño, R. Venegas-Rodriguez, R. Peña-Ruiz, M. Bequet-Romero, R. Santana-Sanchez, E. Penton-Arias, et al. (+3) G. Martinez-Donato, G. Guillén-Nieto, María del Carmen Dominguez-Horta |
| 12 |
[GO] |
2021―Jan―05 |
Stress proteins as predictors of COVID-19 outcomes |
Barry G. Hall |
| 13 |
[GO] |
2020―Nov―16 |
Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention |
Michael Kasperkiewicz |
| 14 |
[GO] |
2020―Sep―05 |
Coronaviruses and stress: from cellular to global |
Lawrence E. Hightower, M. Gabriella Santoro |
| 15 |
[GO] |
2020―Aug―06 |
Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
Edward R. O’Brien, Jagdeep K. Sandhu |
| 16 |
[GO] |
2020―Aug―04 |
Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19 |
Antonella Marino Gammazza, Sébastien Légaré, Giosuè Lo Bosco, Alberto Fucarino, Francesca Angileri, Everly Conway de Macario, et al. (+2) Alberto JL Macario, Francesco Cappello |
| 17 |
[GO] |
2020―Jul―29 |
SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism |
Guglielmo Lucchese, Agnes Flöel |
| 18 |
[GO] |
2020―Jun―29 |
Correction to: COVID-19 and heme oxygenase: novel insight into the disease and potential therapies |
Philip L. Hooper |
| 19 |
[GO] |
2020―Jun―04 |
COVID-19 and heme oxygenase: novel insight into the disease and potential therapies |
Philip L. Hooper |
| 20 |
[GO] |
2020―Jun―02 |
COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? |
Antonio De Maio, Lawrence E. Hightower |
| 21 |
[GO] |
2020―May―26 |
On barring the vascular gateway against severe COVID-19 disease |
George Perdrizet, Lawrence E. Hightower |
| 22 |
[GO] |
2020―May―14 |
Possible application of H2S-producing compounds in therapy of coronavirus (COVID-19) infection and pneumonia |
Mikhail B. Evgen’ev, Anton Frenkel |
| 23 |
[GO] |
2020―Apr―20 |
Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
Francesco Cappello |
